More than 3 years have passed since Coronavirus disease 2019 (COVID‐19) was declared
a global pandemic, yet COVID‐19 still severely impacts immunocompromised individuals …

Patients who undergo hematopoietic stem‐cell transplantation (HSCT) are more susceptible
to developing severe forms of COVID‐19 with an increased risk of mortality. The aim of this …

Risk factors for severe SARS-Cov-2 infection course are poorly described in children
following hematopoietic cell transplantation (HCT). In this international study, we analyzed …

During the COVID-19 pandemic, hematopoietic stem cell transplant (HSCT) recipients faced
an elevated mortality rate from SARS-CoV-2 infection, ranging between 10-40%. The SARS …

Objetivo: evaluar y correlacionar la calidad de vida y la toxicidad financiera de pacientes
adultos sometidos a trasplante de células madre hematopoyéticas durante el período de la …

Objective: to evaluate and correlate the quality of life and financial toxicity of adult patients
undergoing hematopoietic stem cell transplantation during the COVID-19 pandemic …

Objetivo: avaliar e correlacionar a qualidade de vida e a toxicidade financeira dos pacientes
adultos submetidos ao transplante de célulastronco hematopoéticas no período da …

Background Data on the risk factors and outcomes for pediatric patients with SARS‐CoV‐2
infection (COVID‐19) following hematopoietic stem cell transplantation (HSCT) are limited …

Hematopoietic stem cell transplant (HSCT) recipients are at-increased risk for severe COVID-
19. The aim of this study was to evaluate the burden of COVID-19 in a cohort of HSCT …

Data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
patients at early stage of immune reconstitution after hematopoietic stem cell transplantation …